« Back to list Alixorexton (ALKS 2680) Narcolepsy Type 2 Phase 2 Data 11/12/25 at 8:30 AM EST Listen to Webcast Supporting Materials Alixorexton (ALKS 2680) Narcolepsy Type 2 Phase 2 Data Investor Presentation 542.9 KB
